Activation of MMPs by EZH2 angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9: 407–415. 50. Fingleton B (2006) Matrix metalloproteinases: roles in cancer and metastasis. Frontiers in bioscience : a journal and virtual library 11: 479–491. 51. Daja MM, Niu X, Zhao Z, Brown JM, Russell PJ (2003) Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloprotei- nases in prostate cancer cell lines. Prostate cancer and prostatic diseases 6: 15–26. 52. Fujii S, Ito K, Ito Y, Ochiai A (2008) Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation. The Journal of biological chemistry 283: 17324–17332. 53. Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix metallopro- teinases in cancer progression and their pharmacological targeting. The FEBS journal 278: 16–27. PLoS ONE | www.plosone.org 12 January 2012 | Volume 7 | Issue 1 | e30393